5SCHWARZ RE, ZAGALA NEVAREZ K. Recurrence patents after radical gastrectomy for gastric cancer: prognostic factors and impli- cations for postoperative adjuvant therapy. Ann Surg Oneol, 2002, 9 (4): 394-400. 被引量：1
6Piura B. Intraperitoneal chemotherapy in ovarian carcinoma. Hare - fuah, 2001, 140(9) : 844 - 849. 被引量：1
7AzaiK, IwasakiY, TakahashiT. Repeated intraperitoneaI chemothera- py for peritoneal dissemination from gastric carcinoma. Gan To Ka- gaku Ryoho, 2001,28(9) : 1257 - 1261. 被引量：1
8Topuz E, Basaran M, Saip P, et al.Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5 - fluorouracil, and calcium folinate inpatients with gastric cancer: aphases- tudy.Am J Clln Oncol, 2002, 25 (6): 619- 624. 被引量：1
10Lise M, Nitti D, Marchet A, et al. Complementary treatment to surgery of gastric eareinoma: role of adjuvant and neoadjuvant chemotherapy. Chirltal, 1997, 49 (3) : 35 - 39. 被引量：1
7Kim JY, Bae HS. A controlled clinical study of serosa-invasive gastric earcinma patients who underwent surgery plus intraperitoneal hyperthermo-cherno-perfusion(IHCP) [J]. Gastric Cancer, 2001, 4(1): 27-33. 被引量：1
8Jansen M, Fass J, Langejurgen E, et al. Effects of intraperitoneal mitomycin C absorbed on activated carbon on adhesion formation and mesothelial cells in vitro[J]. Eur J Surg, 2000, 166(7) : 572-576. 被引量：1
9Yco CH, Noh SH, Shin DW, et al. Recurrences following curative resection for gastric carcinoma [J ]. Br J Surg, 2000, 87 ( 2 ) : 236-242. 被引量：1
10Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure[J]. J Natl Cancer Inst, 1997, 89(7): 480-487. 被引量：1
